Access. Intelligence. Excellence
JUNE 2017 Research Alert
|This month we added four new studies to the Best Practice Database, the research repository for Best Practices, LLC. Two of the new studies come from research that provides hard-to-find benchmarks regarding oncology product launches in the U.S. One of the oncology studies focuses on how to leverage cost savings from the initial oncology product launch to a second indication launch. The other oncology study provides investment benchmarks for recent launches (2013 and later) and single-indication brands. The last two studies are from our new report on Investigator Initiated Trials (IIT) management. These studies provide benchmarks around staffing and investment as well as measuring performance and communication tactics. |
The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.
|Download: What it takes to Successfully Launch an Oncology Product in the U.S. Marketplace: Leveraging Line Extensions (5462)|
Companies often pursue a second indication for the same oncology product in order to not only expand a product's patient base but also to leverage savings on launch spending. This Best Practices, LLC study includes investment benchmarks across pre-launch, launch and post-launch periods for first indication oncology launches and second indication launches.
||Download: What it takes to Successfully Launch an Oncology Product in the U.S. Marketplace: Recent Launches and Single-Indication Brands (5463)|
Given the complexity of the oncology market, it is sometimes difficult to know where and how much to invest before, during and after a product's launch. This benchmarking study is specifically designed to provide investment and staffing benchmarks for oncology products that were launched in 2013 and later (and have no second indication as of 2017).
||Download: Investigator Initiated Trials Management: Structure and Resource Allocation (5464)|
As companies accelerate their IIT programs, it is critical that they appropriately resource and effectively manage their partnerships with trial leaders. Best Practices, LLC undertook this benchmarking research to provide a detailed roadmap for improving IIT management at biopharmaceutical companies, capturing critical metrics and insights on IIT management team structure, staffing and budget.
||Download: Investigator Initiated Trials Management: Performance Management and Communication Tactics (5465)|
As organizations increase the number of IIT trials to address unmet medical needs, it is important for companies to properly vet each proposal and approve the ones that demonstrate scientific merit. Best Practices, LLC undertook this benchmarking research to capture critical metrics and insights on evaluating IIT proposals as well as improving performance, publication tactics and communication.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE